Obesity trials in Argentina

In Argentina 26 Also abroad 1939

26 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Buenos Aires, Ciudad Autonoma Buenos Aires, Mar del Plata
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Buenos Aires, Ciudad Autonoma Buenos Aires, Mar del Plata
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Buenos Aires, CABA, Ciudad de Buenos Aires, Ramos Mejía, Rosario, San Nicolás
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
Phase 3Taking people
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Where
Buenos Aires, CABA, Ciudad de Buenos Aires, Esperanza, Lanus, Mar del Plata, Mendoza, Rosario, San Isidro, SAN M. de Tucuman, San Nicolás de los Arroyos, Santa Fe
Age
18 years and over
People
2,001 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00
Phase 3Not yet taking people in Argentina
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Where
Buenos Aires, CABA, Capital Federal, Godoy Cruz, Mendoza, Rosario, Santa Rosa, Santiago del Estero
Age
18 years and over
People
1,408 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07919405
Phase 3Taking people
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Where
Buenos Aires, Granadero Baigorria, Rosario, San Fernando, San Isidro, San Juan, SAN M. de Tucuman, San Miguel de Tucumán, San Nicolás
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00
Phase 2Taking people
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Where
Buenos Aires, Rosario, Santa Fe, Santa Rosa
Age
18 years and over
People
120 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07783802
Phase 3Not yet taking people in Argentina
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Where
Bahía Blanca, Buenos Aires, Ciudad de Buenos Aires, Córdoba, Del Viso, Godoy Cruz, Granadero Baigorria, Junín, Mar del Plata, Mendoza, Rosario, SAN M. de Tucuman, Santiago del Estero
Age
18 years and over
People
2,115 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00
Phase 2Not yet taking people in Argentina
A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes
Where
Buenos Aires, Rosario
Age
18 years to 75 years
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07890376
Phase 3Not yet taking people in Argentina
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Buenos Aires, CABA, Córdoba, Granadero Baigorria, Lanus, Mar del Plata, Ramos Mejía, Rosario, San Fernando, San Nicolás, Santa Fe
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Buenos Aires, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Caba, CABA, Ciudad Autonoma de Buenos Aires, Córdoba, Morón, Ramos Meija, Rosario, San Miguel de Tucumán, San Nicolás de los Arroyos, Santa Fe, Villa María, Zárate
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Buenos Aires, CABA, Ciudad de Buenos Aires, Mendoza, Ramos Mejía, Rosario, San Nicolás
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Buenos Aires, CABA, Capital Federal, Granadero Baigorria, Lanus, Rosario, San Nicolás, San Vicente
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 2Taking people
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Where
Buenos Aires, Rosario
Age
18 years to 75 years
People
1,481 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06143956
Phase 3Not yet taking people in Argentina
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Buenos Aires, CABA, Capital Federal, City of Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Corrientes, Formosa, Godoy Cruz, Godoy Cruz, Mendoza, La Plata, Mar del Plata, Río Cuarto, Rosario, Salta, San Martin, San Miguel de Tucumán, San Nicolás, Santa Fe, Zárate
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Buenos Aires, CABA, Capital Federal, Ciudad Autónoma de Buenos Aires, Ciudad de Buenos Aires, San Miguel de Tucumán, Santa Fe, Santiago del Estero
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 3Taking people
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Where
Buenos Aires, Ramos Mejía, SAN M. de Tucuman
Age
12 years to 17 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06439277
Phase 3Taking people
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Where
Buenos Aires, Córdoba, Esperanza, Santa Fe, Godoy Cruz, San Nicolás, Santa Rosa
Age
18 years and over
People
1,150 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07339423 · EU 2024-520440-42-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Buenos Aires, Córdoba, Rosario, San Miguel de Tucumán
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Buenos Aires, CABA, Capital Federal, City of Buenos Aires, Ciudad Autonoma de Buenos Aires, Córdoba, Esperanza, Santa Fe, Godoy Cruz, Mendoza, Lanús Este, La Plata, Buenos Aires, Pilar, Rosario, Salta, San Miguel de Tucumán, San Nicolás, Santa Fe, Santa Rosa, La Pampa
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseTaking people
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
Where
Buenos Aires
Age
18 years and over
People
145
Run by
Hospital Italiano de Buenos Aires
See details and how to joinNCT07621419
Phase 3Not yet taking people in Argentina
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Where
Capital Federal, Córdoba, Lanús Este
Age
18 years and over
People
1,000 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07400107 · EU 2024-520446-31-00
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
City of Buenos Aires, Corrientes, Lanús Este, Mar del Plata
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
No phaseTaking people
Maternal Characteristics Associated With Child Growth and Adiposity
Where
La Plata
Age
18 years to 40 years
People
130
Run by
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
See details and how to joinNCT05798676